ResMed, Inc. (RMD)
235.30
-4.01
(-1.68%)
USD |
NYSE |
Nov 06, 16:00
235.30
0.00 (0.00%)
Pre-Market: 20:00
ResMed Cash from Investing (Quarterly) : 392.06M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 392.06M |
| June 30, 2026 | -383.65M |
| March 31, 2026 | -58.03M |
| December 31, 2025 | -50.94M |
| September 30, 2025 | -52.58M |
| June 30, 2025 | -133.71M |
| March 31, 2025 | -31.79M |
| December 31, 2024 | -36.69M |
| September 30, 2024 | 2.146M |
| June 30, 2024 | -46.51M |
| March 31, 2024 | -33.15M |
| December 31, 2023 | -41.14M |
| September 30, 2023 | -148.98M |
| June 30, 2023 | -46.52M |
| March 31, 2023 | -28.10M |
| December 31, 2022 | -1.026B |
| September 30, 2022 | -58.81M |
| June 30, 2022 | -55.24M |
| March 31, 2022 | -49.50M |
| December 31, 2021 | -83.31M |
| September 30, 2021 | -41.87M |
| June 30, 2021 | -48.07M |
| March 31, 2021 | -58.62M |
| December 31, 2020 | -29.66M |
| September 30, 2020 | -22.11M |
| Date | Value |
|---|---|
| June 30, 2020 | -3.407M |
| March 31, 2020 | -99.61M |
| December 31, 2019 | -43.62M |
| September 30, 2019 | -33.22M |
| June 30, 2019 | -43.89M |
| March 31, 2019 | -225.41M |
| December 31, 2018 | -658.22M |
| September 30, 2018 | -148.19M |
| June 30, 2018 | -38.53M |
| March 31, 2018 | -19.62M |
| December 31, 2017 | -28.26M |
| September 30, 2017 | -15.42M |
| June 30, 2017 | -31.28M |
| March 31, 2017 | -17.92M |
| December 31, 2016 | -19.52M |
| September 30, 2016 | -13.17M |
| June 30, 2016 | -818.16M |
| March 31, 2016 | -83.73M |
| December 31, 2015 | -161.11M |
| September 30, 2015 | -62.75M |
| June 30, 2015 | -23.48M |
| March 31, 2015 | -19.00M |
| December 31, 2014 | -59.00M |
| September 30, 2014 | -41.60M |
| June 30, 2014 | -22.84M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Accuray, Inc. | -- |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | -12.57M |
| Rockwell Medical, Inc. | -0.487M |
| Microbot Medical, Inc. | 4.471M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 422.42M |
| Cash from Financing (Quarterly) | -1.278B |
| Free Cash Flow | 1.588B |
| Free Cash Flow Per Share (Quarterly) | 2.589 |
| Free Cash Flow to Equity (Quarterly) | 586.59M |
| Free Cash Flow to Firm (Quarterly) | 385.06M |
| Free Cash Flow Yield | 4.65% |